Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
Rogelio González‐González(Universidad de la República de Uruguay), Ronell Bologna‐Molina(Universidad de la República de Uruguay), Nelly Molina‐Frechero(Universidad Autónoma Metropolitana), Ramón Gil Carreón-Burciaga(Universidad de la República de Uruguay), Sandra López‐Verdín(Universidad de la República de Uruguay), Mario Alberto Isiordia‐Espinoza(Universidad de Guadalajara), Jesús Lavalle‐Carrasco(Universidad de la República de Uruguay)
Cited by 58
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Physiological Effects and Human Health Benefits of Hibiscus sabdariffa: A Review of Clinical Trials
|Pharmaceuticals|2022|64
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62